Skopos Labs, Inc. Grifols Sa Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
Shares
1 transactions
Others Institutions Holding GRFS
# of Institutions
165Shares Held
152MCall Options Held
76.5KPut Options Held
106K-
Brandes Investment Partners, LP La Jolla, CA25.7MShares$273 Million1.99% of portfolio
-
Capital World Investors Los Angeles, CA21.5MShares$228 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.1MShares$192 Million23.98% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.6MShares$133 Million5.56% of portfolio
-
Armistice Capital, LLC New York, NY9.28MShares$98.3 Million1.01% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $7.2B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...